{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:34:56Z","timestamp":1789425296740,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.vaccine.2011.06.101","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T01:36:15Z","timestamp":1311125775000},"page":"6629-6635","source":"Crossref","is-referenced-by-count":20,"title":["Genetic stability of a dengue vaccine based on chimeric yellow fever\/dengue viruses"],"prefix":"10.1016","volume":"29","author":[{"given":"N.","family":"Mantel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Geny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pontvianne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Barban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.vaccine.2011.06.101_bib0005","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.06.101_bib0010","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-naive children, adolescents, and adults in Mexico City: randomized controlled phase 1 trial of safety and immunogenicity","volume":"30","author":"Poo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.101_bib0160","doi-asserted-by":"crossref","unstructured":"Qiao J, Shaw D, Forrat R, Wartel-Tram A, Lang J. Safety, viremia and immunogenicity of Sanofi Pasteur's tetravalent Dengue vaccine in adults previously exposed to live attenuated flaviviruses. 13th International Congress on Infectious Diseases 2008; Kuala Lumpur, Malaysia.","DOI":"10.1016\/j.ijid.2008.05.360"},{"key":"10.1016\/j.vaccine.2011.06.101_bib0020","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"issue":"3","key":"10.1016\/j.vaccine.2011.06.101_bib0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2011.06.101_bib0030","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2011.06.101_bib0035","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanjuan","year":"2010","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.06.101_bib0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"issue":"15","key":"10.1016\/j.vaccine.2011.06.101_bib0045","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.06.101_bib0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.1966.03110190153047","article-title":"Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child","volume":"198","author":"American Medical Association","year":"1966","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2011.06.101_bib0055","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/JVI.78.2.1032-1038.2004","article-title":"High fidelity of yellow fever virus RNA polymerase","volume":"78","author":"Pugachev","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.06.101_bib0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2008.03.026","article-title":"Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines","volume":"151","author":"Mantel","year":"2008","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2011.06.101_bib0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/viro.2002.1462","article-title":"Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates","volume":"298","author":"Guirakhoo","year":"2002","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2011.06.101_bib0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2011.06.101_bib0075","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1099\/0022-1317-76-11-2749","article-title":"Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine","volume":"76","author":"Wang","year":"1995","journal-title":"J Gen Virol"},{"issue":"5758","key":"10.1016\/j.vaccine.2011.06.101_bib0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1126\/science.1115030","article-title":"Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes","volume":"311","author":"Aaskov","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2011.06.101_bib0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4269\/ajtmh.2004.71.493","article-title":"Genetic and phenotypic variation of West Nile virus in New York, 2000\u20132003","volume":"71","author":"Ebel","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2011.06.101_bib0090","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1099\/vir.0.83061-0","article-title":"Adaptation of two flaviviruses results in differences in genetic heterogeneity and virus adaptability","volume":"88","author":"Ciota","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.06.101_bib0095","unstructured":"Barban V, Mantel M, Gulia S, Girerd Y, Boaz M, Crevat D, et al. Evaluation of neutralizing antibody responses against a large range of wild-type isolates in sera of primates vaccinated with CYD TV DEN vaccine. Manuscript in preparation."},{"issue":"2","key":"10.1016\/j.vaccine.2011.06.101_bib0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vaccin"},{"issue":"2","key":"10.1016\/j.vaccine.2011.06.101_bib0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"5871","key":"10.1016\/j.vaccine.2011.06.101_bib0110","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2011.06.101_bib0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-1702(94)00076-O","article-title":"Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213","volume":"35","author":"dos Santos","year":"1995","journal-title":"Virus Res"},{"issue":"10","key":"10.1016\/j.vaccine.2011.06.101_bib0120","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1093\/nar\/17.10.3989","article-title":"Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines","volume":"17","author":"Dupuy","year":"1989","journal-title":"Nucleic Acids Res"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2011.06.101_bib0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0264-410X(97)00278-8","article-title":"Genetic variability among yellow fever virus 17D substrains","volume":"16","author":"Galler","year":"1998","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2011.06.101_bib0130","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc Natl Acad Sci U. S. A"},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2011.06.101_bib0135","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/S0264-410X(03)00487-0","article-title":"Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2\/4 vaccine candidate in Vero cells","volume":"21","author":"Blaney","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.06.101_bib0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1348-0421.2005.tb03719.x","article-title":"Molecular basis for adaptation of a chimeric dengue type-4\/Japanese encephalitis virus to Vero cells","volume":"49","author":"Tang","year":"2005","journal-title":"Microbiol Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2011.06.101_bib0145","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1128\/JVI.78.18.9998-10008.2004","article-title":"A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia\/viscerotropism for monkeys","volume":"78","author":"Guirakhoo","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.06.101_bib0150","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/527328","article-title":"Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes","volume":"197","author":"McGee","year":"2008","journal-title":"J Infect Dis"},{"issue":"4715","key":"10.1016\/j.vaccine.2011.06.101_bib0155","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11009959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11009959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T04:09:59Z","timestamp":1560398999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11009959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":31,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0264410X11009959"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.101","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}